1060801-92-4 Usage
General Description
3-Trifluoromethyl-pyridine-4-carbaldehyde is a chemical compound with the molecular formula C7H4F3NO. It is a yellowish liquid with a strong, pungent odor. 3-Trifluoromethyl-pyridine-4-carbaldehyde is commonly used as a reagent in organic synthesis, particularly in the preparation of pharmaceuticals and agrochemicals. It is also utilized in the production of various types of dyes and pigments. The trifluoromethyl group in its structure makes it a valuable building block for the synthesis of complex organic molecules. Additionally, the aldehyde functional group makes it an important intermediate in the synthesis of various pharmaceutical compounds and other bioactive molecules. Overall, 3-Trifluoromethyl-pyridine-4-carbaldehyde is a versatile and widely utilized compound in the field of organic chemistry and pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 1060801-92-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,6,0,8,0 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1060801-92:
(9*1)+(8*0)+(7*6)+(6*0)+(5*8)+(4*0)+(3*1)+(2*9)+(1*2)=114
114 % 10 = 4
So 1060801-92-4 is a valid CAS Registry Number.
1060801-92-4Relevant articles and documents
Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy
Lounsbury, Nicole,Mateo, George,Jones, Brielle,Papaiahgari, Srinivas,Thimmulappa, Rajash K.,Teijaro, Christiana,Gordon, John,Korzekwa, Kenneth,Ye, Min,Allaway, Graham,Abou-Gharbia, Magid,Biswal, Shyam,Childers, Wayne
, p. 5352 - 5359 (2015)
Nrf2 activators represent a good drug target for designing agents to treat diseases associated with oxidative stress. Building upon previous work, we designed and prepared a series of heterocyclic chalcone-based Nrf2 activators with reduced lipophilicity
MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF
-
, (2016/09/22)
Provided are novel compounds of Formula (I): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with methyl modifying enzymes. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with methyl modifying enzymes.
